Shockwave Medical
  • Technology
    • Challenges of Calcium
    • Intravascular Lithotripsy (IVL)
    • IVL Applications – International
    • IVL Applications – US
  • Clinicians
    • USA
    • Peripheral
      • Pre-TAVI
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • Coronary
    • Valve
    • International
    • Peripheral
      • Pre-TAVR
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • Coronary
      • CAD Case Library
      • Clinical Evidence
        • CAD I
        • CAD II
        • CAD III
      • Product Specs & Resources
        • Shockwave C2
    • Valve
  • Investors
    • Overview
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
  • About
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • The Catalyst
  • Contact
Home About Blog
catalyst_logo

Welcome to The Catalyst

Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.

ico email Connect

Keep Your Finger on the Pulse: 2020 Peripheral Newsletter

Your first Shockwave IVL newsletter, PulsePoint, has arrived. We’re kicking off with an...

Read More

Real World BTK Data Show IVL Achieves High Lumen Gain with Minimal Complications

The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with...

Read More

EuroPCR: DISRUPT CAD III’s Impact on Clinical Practice

In case you missed its live airing, tune into a great discussion from coronary IVL’s most...

Read More

PAD III on incathlab: Results, Cases & Significance

Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star...

Read More

CAD III: Top 10 OCT Findings

If an image is worth a thousand words, then we’d have to write a novel to capture all of the key...

Read More

Treating Eccentric Calcium: Addressing the ‘Thorn In Your Side’

Eccentric calcium has always been a ‘pain’…a real thorn in the interventionalists’ side.  While...

Read More

IVL in Real-World European Population: Q&A with Dr. Sandeep Basavarajaiah & Dr. Alfonso Ielasi

Dr. Sandeep Basavarajaiah, consultant cardiologist at Heartlands Hospital in Birmingham, UK, and...

Read More

PCR London Valve: Simplify TAVI – Keep it Femoral

At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of...

Read More

CAD III ShockTalk: A Discussion about the Data’s Significance

At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD...

Read More

DISRUPT PAD III: Superior in Prep

In life, and when treating patients, we all prefer things to be less complicated. ...

Read More
1 2 3 4 5 Next >
Topics
  • CAD Applications - Bifurcations
  • CAD Applications - Eccentric Lesions
  • Clinical Corner with Dr. Keith Dawkins
  • Clinical Corner with SW
  • Coronary Cases
  • Coronary Clinical Data
  • Coronary Conferences
  • Coronary IVL
  • DISRUPT CAD
  • DISRUPT PAD
  • IVL Technology
  • Medical Meetings
  • PAD Applications - BTK
  • PAD Applications - CLI
  • PAD Applications - EVAR
  • PAD Applications - Iliac
  • PAD Applications - TAVR Access
  • PAD Applications - TEVAR
  • Peripheral Cases
  • Peripheral Clinical Data
  • Peripheral Conferences
  • Peripheral IVL
  • PulsePoint Newsletter
  • Q&A with Uday
  • Shockwave C2
  • Shockwave M5
  • Shockwave S4
  • SWAV News

Keep Your Finger on the Pulse: 2020 Peripheral Newsletter

Posted by Michelle Revell on Feb 23, 2021 2:20:46 PM
  • Tweet

Your first Shockwave IVL newsletter, PulsePoint, has arrived. We’re kicking off with an ambitious recap of 2020, celebrating key milestones and major events for our customers using our peripheral technology across the globe. Released on a quarterly basis moving forward, PulsePoint will be the one stop shop for all the latest news and updates throughout the year. We hope you enjoy our first global edition of PulsePoint.

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, Peripheral Cases, PulsePoint Newsletter

Real World BTK Data Show IVL Achieves High Lumen Gain with Minimal Complications

Posted by Emma Miller on Feb 19, 2021 4:42:54 PM
  • Tweet

The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, PAD Applications - BTK, PAD Applications - CLI, Peripheral Clinical Data

EuroPCR: DISRUPT CAD III’s Impact on Clinical Practice

Posted by Emma Miller on Feb 19, 2021 4:40:59 PM
  • Tweet

In case you missed its live airing, tune into a great discussion from coronary IVL’s most knowledgeable operators about how they are treating severely calcified lesions, their tips and tricks using IVL in real world practice as well as their clinical experience with IVL.

Read More
0 Comments Click here to read/write comments

Topics: Coronary Cases, Coronary Clinical Data, Shockwave C2

PAD III on incathlab: Results, Cases & Significance

Posted by Emma Miller on Jan 28, 2021 5:20:37 PM
  • Tweet

Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data

CAD III: Top 10 OCT Findings

Posted by Emma Miller on Jan 28, 2021 11:32:38 AM
  • Tweet

If an image is worth a thousand words, then we’d have to write a novel to capture all of the key takeaways from the 300 OCT images (i.e. pre-IVL, post-IVL & post-DES) that were taken from the 100 patients that participated in the Disrupt CAD III OCT sub-analysis. Thankfully, we ditched the novel and opted for an easy-to-digest infographic to capture the 10 most pertinent data points from the OCT study presented at TCT Connect. Happy viewing!

Read More
0 Comments Click here to read/write comments

Topics: Coronary Cases, Coronary Clinical Data, Shockwave C2

Treating Eccentric Calcium: Addressing the ‘Thorn In Your Side’

Posted by Emma Miller on Jan 22, 2021 12:56:59 PM
  • Tweet

Eccentric calcium has always been a ‘pain’…a real thorn in the interventionalists’ side.  While current devices in eccentric calcium often expand the healthy, non-calcified side of the artery or fall subject to wire bias that prevents it from reaching the calcified side of the artery, coronary Intravascular Lithotripsy (IVL) offers a new alternative that can modify both concentric and eccentric calcium equally as well. Don’t be satisfied with less than ideal stent expansion in eccentric calcium, instead learn how Dr. Margaret McEntegart has used IVL to modify eccentric calcium in the left main and hear Profs. Holger Nef & Carlo Di Mario share their recent publications and clinical data comparing IVL outcomes in eccentric and concentric calcified lesions.

 

Assessment and Management of Calcified Coronary Lesions, Part 1/5

 

 

Live in a Box: Left Main Bifurcation Lesion with Eccentric Calcium, Part 2/5

 

 

CAD I/II Analysis: Eccentric Vs. Concentric Lesions, Part 3/5

 

 

Lithotripsy in Eccentric and Concentric Coronary Calcifications, Part 4/5

 

 

Discussion and Conclusion, Part 5/5

 

Read More
0 Comments Click here to read/write comments

Topics: Coronary Cases, Coronary Clinical Data, Shockwave C2, CAD Applications - Eccentric Lesions

IVL in Real-World European Population: Q&A with Dr. Sandeep Basavarajaiah & Dr. Alfonso Ielasi

Posted by Emma Miller on Jan 11, 2021 10:59:35 AM
  • Tweet

Dr. Sandeep Basavarajaiah, consultant cardiologist at Heartlands Hospital in Birmingham, UK, and other leading UK and Italian cardiologists published their initial real-world experience with Intravascular Lithotripsy (IVL) in a real-world population, in Catheter Cardiovasc Interv: “Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study”.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2

PCR London Valve: Simplify TAVI – Keep it Femoral

Posted by Emma Miller on Jan 6, 2021 6:00:00 AM
  • Tweet

At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of IVL- facilitated TAVI. Profs./Drs. Carlo Di Mario, Ole De Backer, Joachim Schofer, Constantin von zur Mühlen used published data and case experiences to illustrate the advantages of using IVL to maintain transfemoral access in TAVI patients with severely calcified iliacs. Considering the importance of reducing complications to minimize hospital stay, the faculty expressed enthusiasm when considering the use of IVL in these very complex patients. Happy viewing!

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data

CAD III ShockTalk: A Discussion about the Data’s Significance

Posted by Emma Miller on Dec 29, 2020 1:49:53 PM
  • Tweet

At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD III study, the largest and most rigorous coronary IVL study to date.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, DISRUPT CAD, Coronary Cases, Coronary Clinical Data

DISRUPT PAD III: Superior in Prep

Posted by Emma Miller on Dec 29, 2020 1:45:56 PM
  • Tweet

In life, and when treating patients, we all prefer things to be less complicated.  Unfortunately, treating peripheral vascular calcification is typically associated with suboptimal vessel expansion and an increased risk of complications.

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data

All posts Next

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin with Shockwave IVL Today

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

info@shockwavemedical.com

  • Technology
    • Challenges of Calcium
    • Intravascular Lithotripsy (IVL)
  • Clinicians
    • US
    • Peripheral
    • Coronary
    • Valve
    • International
    • Peripheral
    • Coronary
    • Valve
  • Investors
  • About Us
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • The Catalyst
  • Contact Us
Follow us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

  • Privacy Policy
  • ISI
  • Patents

© 2019 Shockwave Medical Inc. All rights reserved. | SPL 63333 Rev. A